KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Total Debt (2016 - 2026)

Eli Lilly filings provide 18 years of Total Debt readings, the most recent being $43.4 billion for Q1 2026.

  • On a quarterly basis, Total Debt rose 12.6% to $43.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $43.4 billion, a 12.6% increase, with the full-year FY2025 number at $42.5 billion, up 26.33% from a year prior.
  • Total Debt hit $43.4 billion in Q1 2026 for Eli Lilly, up from $42.5 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $43.4 billion in Q1 2026 to a low of $15.9 billion in Q3 2022.
  • Median Total Debt over the past 5 years was $26.2 billion (2024), compared with a mean of $28.0 billion.
  • Biggest five-year swings in Total Debt: decreased 7.01% in 2022 and later skyrocketed 55.34% in 2023.
  • Eli Lilly's Total Debt stood at $16.2 billion in 2022, then skyrocketed by 55.34% to $25.2 billion in 2023, then surged by 33.37% to $33.6 billion in 2024, then grew by 26.33% to $42.5 billion in 2025, then rose by 2.04% to $43.4 billion in 2026.
  • The last three reported values for Total Debt were $43.4 billion (Q1 2026), $42.5 billion (Q4 2025), and $42.5 billion (Q3 2025) per Business Quant data.